SynthesisOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025
Increased fall risk in people with type 2 diabetes and cardiovascular disease: a systematic review and meta-analysis.
Synthesis in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cardiovascular Disease and Fracture Risk in People with Type 2 Diabetes: A Nationwide Matched Case-Control Study.Calcified tissue international · 2026Article
- An Exploratory Analysis of Postural Control in People with Type 2 Diabetes Mellitus Using a Smartphone IMU Sensor.Sensors (Basel, Switzerland) · 2026Article
- The DiaActive study: feasibility, safety and acceptability of a fall-preventive rhythm- and ADL-based exercise protocol for older adults with type 2 diabetes.Aging clinical and experimental research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
People with type 2 diabetes (T2D) have an increased risk of falls, a concern further complicated by cardiovascular disease (CVD). Falls pose significant risks of morbidity and mortality, yet the interplay between T2D, CVD, and fall risk remains insufficiently understood. This study aimed to systematically assess the current evidence and estimate the risk of falls in people with coexisting T2D and CVD. A systematic literature search and a meta-analysis were conducted utilizing PubMed, Embase, and Cochrane using PRISMA guidelines. Studies assessing fall risk in people with T2D, with or without CVD, were included. Quality assessment was performed using validated tools such as JADAD, NOS, and GRADE. Existing literature indicates that people with T2D and coexisting CVD have a significantly higher risk of falls compared to those with T2D without CVD. This association was confirmed by the meta-analysis, which demonstrated a pooled odds ratio of 1.29 (95% CI 1.03-1.63). However, clear associations between specific cardiovascular outcomes-such as hypertension, orthostatic hypotension, heart failure, atrial fibrillation, and ischemic disease-and fall risk remained inconclusive. Some studies indicated that autonomic dysfunction, postural instability, and blood pressure dysregulation contributed to fall risk, but findings were inconsistent. The heterogeneity in study methodologies, outcome measures, and sample populations limits definitive conclusions. This review and meta-analysis found an increased fall risk in people with T2D and coexisting CVD; however, current evidence remains insufficient to establish a definitive causal relationship between CVD and fall risk, despite the observed higher fall prevalence.
Indexed as
Identifiers
40850996What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.